Effects of prasugrel, ticagrelor, and clopidogrel on endothelial function and platelet reactivity in patients with stable coronary artery disease one month after percutaneous coronary intervention

Trial Profile

Effects of prasugrel, ticagrelor, and clopidogrel on endothelial function and platelet reactivity in patients with stable coronary artery disease one month after percutaneous coronary intervention

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Apr 2014

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Apr 2014 New trial record
    • 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top